University of Nevada, Las Vegas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Nevada, Las Vegas sits in the top decile of US sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count).
University of Nevada, Las Vegas: 52 sponsored US clinical trials, 17 recruiting.
University of Nevada, Las Vegas sponsors 52 registered US clinical trials on ClinicalTrials.gov, 17 of them currently recruiting, and 31 completed. 2 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Inflammation Biomarkers, with 3 trials.
Top-decile sponsor footprint
University of Nevada, Las Vegas ranks in the top decile of sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
31 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
52 total, page 2 of 2
Cervical Spine Manipulation Affects on Balance and Proprioception
NCT01745705
Development of a Clinical Prediction Rulefor Neck Manipulation
NCT01620905
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 4 | 2 |
What is open in the University of Nevada, Las Vegas pipeline
17 recruiting of 52 indexed (33% open); 31 completed (60%).
Phase mix: 2 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Inflammation Biomarkers (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Nevada, Las Vegas: open-pipeline peers nationwide
Peers matched on 52 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
University of Nevada, Las Vegas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 52 trials (± recruiting share)
- Albany Medical College · 52 trials · 13% recruiting
- Burzynski Research Institute · 52 trials · 0% recruiting
- Dr. Reddy's Laboratories Limited · 52 trials · 0% recruiting
- PTC Therapeutics · 52 trials · 2% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Kessler Foundation · 33% recruiting · 104 trials
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
Related
What to do with this University of Nevada, Las Vegas page
52 registered trials is a research-attention snapshot, not an endorsement of University of Nevada, Las Vegas or any single study.
- 17 of University of Nevada, Las Vegas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Inflammation Biomarkers is the condition University of Nevada, Las Vegas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation Biomarkers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Nevada, Las Vegas pipeline card: 52 registered trials from official public datasets.Report a data error.